Eli Lil­ly, No­var­tis back a biotech start­up boast­ing 'best of both world­s' pro­tein de­graders

Since head­ing up Glax­o­SmithK­line’s pro­tein degra­da­tion unit in 2012, Ian Churcher has wit­nessed a rapid ex­plo­sion of in­ter­est in the idea of lever­ag­ing the body …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER